Ruxolitinib as a therapy choice for refractory pruritus in a patient with essential thrombocythemia with CALR mutation
<p>Refractory pruritus associated with Essential Thrombocythemia (ET) is rare. Herein, we present the first report of resistant pruritus responsive to ruxolitinib in an ET patient with a calreticulin mutation.</p>
Enregistré dans:
| Auteurs principaux: | , |
|---|---|
| Format: | Livre |
| Publié: |
Global Journal of Medical and Clinical Case Reports - Peertechz Publications,
2023-01-25.
|
| Sujets: | |
| Accès en ligne: | Connect to this object online. |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
MARC
| LEADER | 00000 am a22000003u 4500 | ||
|---|---|---|---|
| 001 | peertech__10_17352_2455-5282_000167 | ||
| 042 | |a dc | ||
| 100 | 1 | 0 | |a Kubra Cerci |e author |
| 700 | 1 | 0 | |a Pusem Patir |e author |
| 245 | 0 | 0 | |a Ruxolitinib as a therapy choice for refractory pruritus in a patient with essential thrombocythemia with CALR mutation |
| 260 | |b Global Journal of Medical and Clinical Case Reports - Peertechz Publications, |c 2023-01-25. | ||
| 520 | |a <p>Refractory pruritus associated with Essential Thrombocythemia (ET) is rare. Herein, we present the first report of resistant pruritus responsive to ruxolitinib in an ET patient with a calreticulin mutation.</p> | ||
| 540 | |a Copyright © Kubra Cerci et al. | ||
| 546 | |a en | ||
| 655 | 7 | |a Case Study |2 local | |
| 856 | 4 | 1 | |u https://doi.org/10.17352/2455-5282.000167 |z Connect to this object online. |